Home
Alphabetical

OTHER

Directory Results for (the Company) issued a press release announcing its financial results for the three and nine to (the Company) on March 31, 2015, pursuant to the Companys automatic shelf registration statement on S-3 (File

(the Company) issued a press release announcing its financial results for the three and nine - (the Company) issued a press release announcing its financial results for the three and six months ended

(the Company) issued a press release announcing its financial results for the three and six months ended December 31, - (the Company) issued a press release announcing its financial results for the three months

(the Company) issued a press release announcing its financial results for the three months and fiscal - (the Company) issued a press release announcing its financial results for the three months ended

(the Company) issued a press release announcing its financial results for the three months ended June 30, 2019 - (the Company) issued a press release announcing its financial results for the three months ended September 30, 2013

(the Company) issued a press release announcing its financial results for the year and quarter ended - (the Company) issued a press release announcing its financial results for the year ended December 31, 2016

(the Company) issued a press release announcing its financial results for the year ended December 31, 2021 - (the Company) issued a press release announcing its fourth quarter 2018 financial results and a detailed earnings presentation

(the Company) issued a press release announcing its fourth quarter and full year - (the Company) issued a press release announcing its operating results for the

(the Company) issued a press release announcing its operating results for the first - (the Company) issued a press release announcing its operating results for the quarter ended March 31, 2016

(the Company) issued a press release announcing its operating results for the quarter ended March 31, 2017 - (the Company) issued a press release announcing its operating results for the three

(the Company) issued a press release announcing its plan to reorganize the Companys business structure, effective as - (the Company) issued a press release announcing its presentation of positive

(the Company) issued a press release announcing its pro a financial results for the quarter ended - (the Company) issued a press release announcing its results for its first quarter ended March 31, 2018

(the Company) issued a press release announcing its results for the fourth quarter and full year ended - (the Company) issued a press release announcing its results for the quarter ended June 30,

(the Company) issued a press release announcing its results for the quarter ended June 30, 2018 - (the Company) issued a press release announcing its results for the quarter ended March 31, 2020

(the Company) issued a press release announcing its results for the quarter ended September 30, - (the Company) issued a press release announcing its results for the three months ended March 31, 2018

(the Company) issued a press release announcing its results of - (the Company) issued a press release announcing its unaudited results of operations for the three and nine months ended

(the Company) issued a press release announcing its unaudited results of operations for the three months ended March 31, - (the Company) issued a press release announcing new immune data from its ongoing ADXS-NEO Phase 1 clinical

(the Company) issued a press release announcing operating and financial highlights for the quarter ended March 31, 2023 - (the Company) issued a press release announcing preliminary financial results for the

(the Company) issued a press release announcing results for the fiscal quarter ended - (the Company) issued a press release announcing that additional positive data in its Pompe Disease

(the Company) issued a press release announcing that an Independent Data Safety Monitoring Board - (the Company) issued a press release announcing that it closed its

(the Company) issued a press release announcing that it had priced the previously - (the Company) issued a press release announcing that it has closed on its acquisition of RoseRock Healthcare, a

(the Company) issued a press release announcing that it has completed a Phase 1 - (the Company) issued a press release announcing that it has extended the expiration

(the Company) issued a press release announcing that it has launched an amendment to its Term Loan Credit - (the Company) issued a press release announcing that it has received

(the Company) issued a press release announcing that it has received 510(k) clearance from the U - (the Company) issued a press release announcing that it will host a conference call at 8:30 a

(the Company) issued a press release announcing that it will host a conference call at 9:00 a - (the Company) issued a press release announcing that its Board of Directors has unanimously rejected an

(the Company) issued a press release announcing that its Chief Executive Officer and President - (the Company) issued a press release announcing that its subsidiary

(the Company) issued a press release announcing that NASDAQ has halted trading of the Companys - (the Company) issued a press release announcing that our Board of Directors has declared a cash

(the Company) issued a press release announcing that preclinical data from studies supported by the Company at the - (the Company) issued a press release announcing that Seamus Lagan, our Chief Executive Officer, would be

(the Company) issued a press release announcing that Seamus Lagan, our Chief Executive Officer, would be interviewed on - (the Company) issued a press release announcing that the Company and with its partner Celularity, Inc

(the Company) issued a press release announcing that the Company had decided to - (the Company) issued a press release announcing that the Company has rescheduled the date for its 2018

(the Company) issued a press release announcing that the first patient in the - (the Company) issued a press release announcing that the underwriters of its recent public offering

(the Company) issued a press release announcing that the United States Food and Drug Administration has lifted - (the Company) issued a press release announcing that Tony L

(the Company) issued a press release announcing that, on November 6, 2018, its - (the Company) issued a press release announcing the approval of the listing of its shares of common

(the Company) issued a press release announcing the closing of its previously announced underwritten public - (the Company) issued a press release announcing the Companys earnings for the quarter

(the Company) issued a press release announcing the Companys earnings for the second quarter of fiscal 2022 ended July 30, 2022 - (the Company) issued a press release announcing the Companys financial results for the

(the Company) issued a press release announcing the Companys financial results for the first quarter ended - (the Company) issued a press release announcing the Companys first quarter 2016 financial results

(the Company) issued a press release announcing the Companys fourth quarter 2014 financial results - (the Company) issued a press release announcing the Companys results of operations for the fourth

(the Company) issued a press release announcing the Companys results of operations for the second - (the Company) issued a press release announcing the decision of the Office Director (the Director) of the

(the Company) issued a press release announcing the decision of the U - (the Company) issued a press release announcing the filing of its 2006 annual report on 10-K - filings irdirect

(the Company) issued a press release announcing the filing of its 510(k) submission to the - (the Company) issued a press release announcing the PDUFA Date for IV 30mg

(the Company) issued a press release announcing the planned change in its ticker symbol on the New York Stock - (the Company) issued a press release announcing the pricing of $270,000,000 aggregate principal amount of

(the Company) issued a press release announcing the pricing of its offering of - (the Company) issued a press release announcing the resubmission of the Companys New Drug Application

(the Company) issued a press release announcing the results of its first interim analysis of its Phase 2B - (the Company) issued a press release announcing the timely completion of its plan to return $1 billion of capital to

(the Company) issued a press release announcing the withdrawal of its 510(k) - (the Company) issued a press release announcing two late-breaking

(the Company) issued a press release announcing U - (the Company) issued a press release announcing updated survival data in the Phase 1/2 ADXS-PSA Trial at

(the Company) issued a press release announcing, among other things, that the U - (the Company) issued a press release disclosing certain details regarding its More Roads to HarleyDavidson growth plan

(the Company) issued a press release disclosing its results - (the Company) issued a press release discussing results of operations for the fourth quarter ended

(the Company) issued a press release discussing results of operations for the quarter - (the Company) issued a press release discussing results of operations for the second quarter ended June 30,

(the Company) issued a press release discussing results of operations for the third - (the Company) issued a press release in Canada pursuant to TSX Venture Exchange

(the Company) issued a press release made pursuant to Rule 135c promulgated under the Securities Act of 1933, as amended (the - (the Company) issued a press release on December 5, 2017, announcing clinical results from its SAKURA 1 and SAKURA 2

(the Company) issued a press release on February 14, 2018, disclosing financial ination and - (the Company) issued a press release on March 21, 2018 announcing its financial results for the quarter and fiscal year ended February 3, 2018

(the Company) issued a press release on May 15, 2019, disclosing financial ination and operating metrics for its three month - (the Company) issued a press release on May 24, 2017 announcing its financial results for the quarter ended April 29, 2017

(the Company) issued a press release on May 25, 2016 announcing its financial results for the quarter ended April 30, 2016 - (the Company) issued a press release on November 21, 2017 announcing its financial results for the quarter ended October 28, 2017

(the Company) issued a press release on November 28, 2018 announcing its financial results for the quarter ended November 3, 2018 - (the Company) issued a press release providing a preliminary report of the Companys revenue for the

(the Company) issued a press release providing an update on the year ended - (the Company) issued a press release regarding its consolidated financial

(the Company) issued a press release regarding its consolidated financial results - (the Company) issued a press release regarding its financial and operational results for the quarter

(the Company) issued a press release regarding its financial results for the first quarter ended March 31, 2019, a - (the Company) issued a press release regarding its financial results for the three months and year

(the Company) issued a press release regarding its results of operations and financial condition for the full year - (the Company) issued a press release regarding its results of operations and financial condition for the quarter ended

(the Company) issued a press release regarding revenues and earnings for Greystone - (the Company) issued a press release reporting its earnings results for its fourth quarter and

(the Company) issued a press release reporting its financial - (the Company) issued a press release reporting its financial results for the quarter and year-to-date

(the Company) issued a press release reporting its financial results for the quarter and year-to-date period - (the Company) issued a press release reporting our financial results for the quarter and year

(the Company) issued a press release reporting the financial results of the Company for its year ended - (the Company) issued a press release this morning, announcing its earnings for the quarter ended March 31,

(the Company) issued a press release this morning, July 29, 2008, announcing its earnings for the quarter ended - (the Company) issued a press release to announce that Ronald P

(the Company) issued a press release to provide an update on the status of its 510(k) - (the Company) issued a press release to report the Companys earnings for the fiscal quarter ended

(the Company) issued a press release to report the Companys earnings for the fiscal quarter ended June 30, 2018, which is attached to this report as - (the Company) issued a press release to report the Companys earnings for the quarter ended March 31, 2020, which

(the Company) issued a press release which reports its financial results for the three and twelve months ended - (the Company) issued a press release, the text of which is attached hereto as Exhibit 99

(the Company) issued a press release, which is attached to this report as Exhibit 99 - (the Company) issued a summary press release and a detailed earnings presentation announcing its first quarter 2018 financial results

(the Company) issued a summary press release and a detailed earnings presentation announcing its second quarter 2018 financial results - (the Company) issued an aggregate of 3,900 shares of its common stock, par

(the Company) issued an aggregate of 6,404,167 units (Units) to certain - (the Company) issued and sold 1,250,000,000 of its 1

(the Company) issued and sold to entities affiliated with Technology Crossover Ventures an aggregate of 312,500 - (the Company) issued the attached press release

(the Company) issued the attached press release, which is being furnished and not filed, and is - (the Company) issued the press release attached hereto as Exhibit 99 - filings irdirect

(the Company) made available a presentation titled Accounting Impact of Business Model Changes and New - (the Company) made available an updated investor relations presentation, which includes

(the Company) made available on its corporate website (www - (the Company) management intends to make a presentation to various investors, analysts and others during an Investor & Analyst

(the Company) MANUAL PREPARED IN ACCORDANCE ... - (the Company) may obtain ination about you from a

(the Company) may obtain ination about you from a consumer reporting agency - (the Company) may request a comprehensive review of your

(the Company) may request from a consumer reporting agency and for - (the Company) may request, for lawful employment purposes, background ination about you from a consumer reporting agency in connection with your employment or application for employment (including independent contractor assignments, as

(the Company) named Ottavio V - (the Company) now appoint I

(the Company) of her resignation from her position as the Companys Chief - (the Company) on April 12, 2011, pursuant to the Companys automatic shelf registration

(the Company) on April 23, 2018 pursuant to the Companys automatic shelf registration statement on S-3 (File - (the Company) on April 26, 2017, pursuant to the Companys automatic shelf registration statement on S-3 (File

(the Company) on April 30, 2013, pursuant to the Companys automatic shelf registration statement on S-3 (File No - (the Company) on December 16, 2014, pursuant to the Companys automatic shelf registration statement on S-3 (File

(the Company) on February 1, 2013, pursuant to the Companys automatic shelf registration statement on S-3 (File No - (the Company) on January 20, 2012, pursuant to the Companys automatic shelf registration statement on S-3 (File No

(the Company) on January 22, 2013, pursuant to the Companys automatic shelf registration statement on S-3 (File No - (the Company) on July 16,

(the Company) on July 8, 2014, pursuant to the Companys automatic shelf registration statement on S-3 (File - (the Company) on March 21, 2011, pursuant to the Companys automatic shelf registration

(the Company) on March 22, 2011, pursuant to the Companys automatic shelf registration - (the Company) on March 27, 2017 pursuant to the Companys automatic shelf registration statement on S-3 (File

(the Company) on March 30, 2015, pursuant to the Companys automatic shelf registration statement on S-3 (File - (the Company) on March 31, 2015, pursuant to the Companys automatic shelf registration statement on S-3 (File